Klin Monbl Augenheilkd 2016; 233(02): 148-153
DOI: 10.1055/s-0041-110397
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Lebensqualität bei Glaukompatienten

Quality of Life in Patients with Glaucoma
C. Hirneiss
1   Glaucoma Unit, Augenklinik der Ludwig-Maximilians Universität München
,
K. Kortüm
2   Ophthalmologie, Augenklinik der Ludwig-Maximilians Universität München
› Author Affiliations
Further Information

Publication History

eingereicht 10 November 2015

akzeptiert 24 November 2015

Publication Date:
15 February 2016 (online)

Zusammenfassung

Hintergrund: Das Ziel der Glaukomtherapie ist der Erhalt der Lebensqualität mit minimalen Nebenwirkungen, minimalen Einschränkungen für den Patienten bei vertretbaren Kosten. In diesem Review sollen aktuelle Erkenntnisse zum Stand von Messung und Bedeutung der Lebensqualität bei Glaukompatienten dargestellt werden. Methoden: Mittels einer semistrukturierten Literaturrecherche in gängigen Datenbanken und Suchmaschinen (insbesondere Medline, Embase, Google) wurde nach relevanten Veröffentlichungen zu den Suchbegriffen „Lebensqualität“ und „Glaukom“ gesucht. Die Ergebnisse wurden thematisch gegliedert dargestellt. Ergebnisse: Zur Messung der Lebensqualität bei Glaukompatienten können etablierte Fragebogeninstrumente und Nutzwertinstrumente eingesetzt werden; aufwendiger sind „performance-based measures“. Ein im deutschen Sprachraum nach Rasch-Analyse glaukomspezifischer Fragebogen ist der Glaucoma-Activity-Limitation-9-Fragebogen (GAL-9). Mit zunehmender Verschlechterung des Gesichtsfelds kommt es zu einer Abnahme der visuellen Lebensqualität. Während bei Augenerkrankungen mit zentralen Gesichtsfelddefekten mehr das bessere Auge die Lebensqualität determiniert, hat beim Glaukom mit peripheren Defekten das schlechtere Auge einen stärkeren Einfluss. Strukturelle Veränderungen korrelieren mit der Lebensqualität schwächer als funktionelle Beeinträchtigungen. Erste Erkenntnisse gibt es zu Mustern im Gesichtsfeldausfall und Korrelation mit der subjektiven Störung. Schlussfolgerungen: Das Wissen um die Lebensqualität ermöglicht es, die Beeinträchtigung des individuellen Patienten besser einzuordnen und können helfen, die Beratung und Therapie von Patienten mit Glaukom zu verbessern.

Abstract

Background: The goal of glaucoma treatment is to maintain the patientʼs visual function and related quality of life, at a sustainable cost. In this review, methods of measuring quality of life are presented, together with their impact in clinical practice. Methods: Searches were from the inception of the database to date. Electronic databases searched included Medline (Ovid), Medline In-Process (Ovid), and Embase (Ovid). In a semistructured approach, the articles were checked for their eligibility to provide information about the measurement and application of quality of life in glaucoma patients. Results: Well established questionnaires are available to measure quality of life in glaucoma patients, as well as instruments to measure benefits. Performance-based measures are more time-consuming. The Glaucoma Activity Limitation-9 Questionnaire (GAL-9) is a glaucoma-specific questionnaire in German, with a Rasch analysis. In eye diseases with central visual field defects, it is the better eye that determines the patientʼs quality of life, whereas in glaucoma patients with peripheral defects, it is the worse eye that has a stronger influence. Structural changes in glaucoma are less well correlated with quality of life than are functional impairments. There have been a few initial reports of patterns of visual field defects that correlate with subjective impairments. Conclusions: The data can help to improve our understanding of individual patient impairment and support our efforts to improve the medical advice and therapy that these patients receive.

 
  • Literatur

  • 1 Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267
  • 2 Gutierrez P, Wilson MR, Johnson C et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 1997; 115: 777-784
  • 3 Jampel HD, Frick KD, Janz NK et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol 2007; 144: 238-244
  • 4 Janz NK, Wren PA, Lichter PR et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001; 108: 1954-1965
  • 5 Deramo VA, Cox TA, Syed AB et al. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2003; 121: 1297-1302
  • 6 Glen FC, Crabb DP, Garway-Heath DF. The direction of research into visual disability and quality of life in glaucoma. BMC Ophthalmol 2011; 11: 19
  • 7 Waisbourd M, Parker S, Ekici F et al. A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology. BMC Ophthalmol 2015; 15: 91
  • 8 Finger R, Hoffmann AE, Fenwick EK et al. Patientsʼ preferences in treatment for neovascular age-related macular degeneration in clinical routine. Br J Ophthalmol 2012; 96: 997-1002
  • 9 Hirneiss C, Neubauer AS, Gass CA et al. Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol 2007; 91: 481-484
  • 10 Pesudovs K, Gothwal VK, Wright T et al. Remediating serious flaws in the National Eye Institute Visual Function Questionnaire. J Cataract Refract Surg 2010; 36: 718-732
  • 11 Gothwal VK, Wright TA, Lamoureux EL et al. Rasch analysis of visual function and quality of life questionnaires. Optom Vis Sci 2009; 86: 1160-1168
  • 12 Pesudovs K, Burr JM, Harley C et al. The development, assessment, and selection of questionnaires. Optom Vis Sci 2007; 84: 663-674
  • 13 Severn P, Fraser S, Finch T et al. Which quality of life score is best for glaucoma patients and why?. BMC Ophthalmol 2008; 8: 2
  • 14 Goldberg I, Clement CI, Chiang TH et al. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma 2009; 18: 6-12
  • 15 Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 2008; 17: 546-551
  • 16 Nelson P, Aspinall P, OʼBrien C. Patientsʼ perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol 1999; 83: 546-552
  • 17 Nelson P, Aspinall P, Papasouliotis O et al. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003; 12: 139-150
  • 18 Khadka J, Pesudovs K, McAlinden C et al. Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis. Invest Ophthalmol Vis Sci 2011; 52: 6971-6977
  • 19 Hirneiss C, Vogel M, Kampik A et al. [Measurement of glaucoma-specific functionality with the GQL-15 and correlation with parameters of visual function.]. Ophthalmologe 2011; 108: 939-946
  • 20 von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. 3rd ed. Princeton, NJ: Princeton University Press; 1953: 15-16
  • 21 Kobelt G, Jonsson B, Bergstrom A et al. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 2006; 84: 363-371
  • 22 Hirneiss C, Neubauer AS, Tribus C et al. [Value-based medicine in ophthalmology]. Ophthalmologe 2006; 103: 493-500
  • 23 Zhang S, Liang Y, Chen Y et al. Utility analysis of vision-related quality of life in patients with glaucoma and different perceptions from ophthalmologists. J Glaucoma 2015; 24: 508-514
  • 24 Jampel HD, Schwartz A, Pollack I et al. Glaucoma patientsʼ assessment of their visual function and quality of life. J Glaucoma 2002; 11: 154-163
  • 25 Friedman SM, Munoz B, Rubin GS et al. Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci 1999; 40: 858-864
  • 26 Lamoureux EL, Hassell JB, Keeffe JE. The determinants of participation in activities of daily living in people with impaired vision. Am J Ophthalmol 2004; 137: 265-270
  • 27 West SK, Rubin GS, Broman AT et al. How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation. Arch Ophthalmol 2002; 120: 774-780
  • 28 Lorenzana L, Lankaranian D, Dugar J et al. A new method of assessing ability to perform activities of daily living: design, methods and baseline data. Ophthalmic Epidemiol 2009; 16: 107-114
  • 29 Richman J, Lorenzana LL, Lankaranian D et al. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol 2010; 17: 144-151
  • 30 Camp A, Wellik SR, Tzu JH et al. Dry eye specific quality of life in veterans using glaucoma drops. Cont Lens Anterior Eye 2015; 38: 220-225
  • 31 Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol 2012; 153: 1-9 e2
  • 32 Takahashi GI, Otori Y, Urashima M et al. Evaluation of quality of life in Japanese glaucoma patients and its relationship with visual function. J Glaucoma 2015; [Epub ahead of print] PMID: 25827300
  • 33 Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415
  • 34 Tubach F, Wells GA, Ravaud P et al. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. J Rheumatol 2005; 32: 2025-2029
  • 35 Kvien TK, Heiberg T, Hagen KB. Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?. Ann Rheum Dis 2007; 66 (Suppl. 03) iii40-41
  • 36 Submacular Surgery Trials Research Group. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19. Ophthalmic Epidemiol 2007; 14: 205-215
  • 37 Hirneiss C, Kampik A, Neubauer AS. [Value-based medicine for glaucoma]. Ophthalmologe 2010; 107: 223-227
  • 38 Abe RY, Gracitelli CP, Diniz-Filho A et al. Frequency doubling technology perimetry and changes in quality of life of glaucoma patients: a longitudinal study. Am J Ophthalmol 2015; 160: 114-122 e1
  • 39 Medeiros FA, Gracitelli CP, Boer ER et al. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 2015; 122: 293-301
  • 40 Bechetoille A, Arnould B, Bron A et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL36-item questionnaire. Acta Ophthalmol Scand 2008; 86: 71-80
  • 41 Chan EW, Chiang PP, Liao J et al. Glaucoma and associated visual acuity and field loss significantly affect glaucoma-specific psychosocial functioning. Ophthalmology 2015; 122: 494-501
  • 42 Hirneiss C, Reznicek L, Vogel M et al. The impact of structural and functional parameters in glaucoma patients on patient-reported visual functioning. PLoS One 2013; 8: e80757
  • 43 Gracitelli CP, Abe RY, Tatham AJ et al. Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma. JAMA Ophthalmol 2015; 133: 384-390
  • 44 Brown MM, Brown GC, Sharma S et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001; 108: 643-647
  • 45 Khadka J, Pesudovs K, McAlinden C et al. Re-engineering the Glaucoma Quality of Life-15 Questionnaire with Rasch Analysis. Invest Ophthalmol Vis Sci 2011; 52: 6971-6977
  • 46 Hirneiss C. The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life. Clin Ophthalmol 2014; 8: 1703-1709
  • 47 Altangerel U, Spaeth GL, Steinmann WC. Assessment of function related to vision (AFREV). Ophthalmic Epidemiol 2006; 13: 67-80
  • 48 Warrian KJ, Altangerel U, Spaeth GL. Performance-based measures of visual function. Surv Ophthalmol 2010; 55: 146-161
  • 49 Murata H, Hirasawa H, Aoyama Y et al. Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS One 2013; 8: e58695
  • 50 Cheng HC, Guo CY, Chen MJ et al. Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol 2015; 133: 269-275
  • 51 Gothwal VK, Bharani S, Mandal AK. Quality of life of caregivers of children with congenital glaucoma: development and validation of a novel questionnaire (CarCGQoL). Invest Ophthalmol Vis Sci 2015; 56: 770-777